207 related articles for article (PubMed ID: 37234172)
21. Lysyl-tRNA synthetase-generated lysyl-adenylate is a substrate for histidine triad nucleotide binding proteins.
Chou TF; Wagner CR
J Biol Chem; 2007 Feb; 282(7):4719-4727. PubMed ID: 17158446
[TBL] [Abstract][Full Text] [Related]
22. Typical antimicrobials induce mast cell degranulation and anaphylactoid reactions via MRGPRX2 and its murine homologue MRGPRB2.
Zhang T; Che D; Liu R; Han S; Wang N; Zhan Y; Pundir P; Cao J; Lv Y; Yang L; Wang J; Ding M; Dong X; He L
Eur J Immunol; 2017 Nov; 47(11):1949-1958. PubMed ID: 28688196
[TBL] [Abstract][Full Text] [Related]
23. Chapter 1: The physiological role of lysyl tRNA synthetase in the immune system.
Nechushtan H; Kim S; Kay G; Razin E
Adv Immunol; 2009; 103():1-27. PubMed ID: 19755181
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2.
Yao C; Ye W; Chen M
Dis Markers; 2023; 2023():9049256. PubMed ID: 36712922
[TBL] [Abstract][Full Text] [Related]
25. Lactic acid suppresses MRGPRX2 mediated mast cell responses.
Syed M; Kammala AK; Callahan B; Oskeritzian CA; Subramanian H
Cell Immunol; 2021 Oct; 368():104422. PubMed ID: 34399172
[TBL] [Abstract][Full Text] [Related]
26. MRGPRX2 and Immediate Drug Hypersensitivity: Insights From Cultured Human Mast Cells.
Elst J; Sabato V; Faber MA; Bridts CH; Mertens C; Van Houdt M; Van Gasse AL; Hagendorens MM; Van Tendeloo V; Maurer M; Campillo-Davo D; Timmermans JP; Pintelon I; Ebo DG
J Investig Allergol Clin Immunol; 2021 Dec; 31(6):489-499. PubMed ID: 32732181
[TBL] [Abstract][Full Text] [Related]
27. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway.
Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T
J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860
[TBL] [Abstract][Full Text] [Related]
28. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells
Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H
Front Immunol; 2022; 13():1032497. PubMed ID: 36275707
[TBL] [Abstract][Full Text] [Related]
29. Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast Cells.
Wang Z; Franke K; Zuberbier T; Babina M
J Invest Dermatol; 2022 Feb; 142(2):414-424.e8. PubMed ID: 34329659
[TBL] [Abstract][Full Text] [Related]
30. Patient Characteristics Associated With Reactions to Mrgprx2-Activating Drugs in an Electronic Health Record-Linked Biobank.
Foer D; Wien M; Karlson EW; Song W; Boyce JA; Brennan PJ
J Allergy Clin Immunol Pract; 2023 Feb; 11(2):492-499.e2. PubMed ID: 36356925
[TBL] [Abstract][Full Text] [Related]
31. Resveratrol inhibits MRGPRX2-mediated mast cell activation via Nrf2 pathway.
Wang J; Zhang Y; Hu S; Ge S; Jia M; Wang N
Int Immunopharmacol; 2021 Apr; 93():107426. PubMed ID: 33550032
[TBL] [Abstract][Full Text] [Related]
32. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target.
Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH
Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512
[TBL] [Abstract][Full Text] [Related]
33. Cisatracurium induces mast cell activation and pseudo-allergic reactions via MRGPRX2.
Che D; Rui L; Cao J; Wang J; Zhang Y; Ding Y; Zhao T; Ma P; An H; Gao Z; Zhang T
Int Immunopharmacol; 2018 Sep; 62():244-250. PubMed ID: 30032049
[TBL] [Abstract][Full Text] [Related]
34. A group of cationic amphiphilic drugs activates MRGPRX2 and induces scratching behavior in mice.
Wolf K; Kühn H; Boehm F; Gebhardt L; Glaudo M; Agelopoulos K; Ständer S; Ectors P; Zahn D; Riedel YK; Thimm D; Müller CE; Kretschmann S; Kremer AN; Chien D; Limjunyawong N; Peng Q; Dong X; Kolkhir P; Scheffel J; Søgaard ML; Weigmann B; Neurath MF; Hawro T; Metz M; Fischer MJM; Kremer AE
J Allergy Clin Immunol; 2021 Aug; 148(2):506-522.e8. PubMed ID: 33617860
[TBL] [Abstract][Full Text] [Related]
35. Mutation in KARS: A novel mechanism for severe anaphylaxis.
Ribó P; Guo Y; Aranda J; Ainsua-Enrich E; Navinés-Ferrer A; Guerrero M; Pascal M; de la Cruz C; Orozco M; Muñoz-Cano R; Martin M
J Allergy Clin Immunol; 2021 May; 147(5):1855-1864.e9. PubMed ID: 33385443
[TBL] [Abstract][Full Text] [Related]
36. Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF.
Babina M; Guhl S; Artuc M; Zuberbier T
Allergy; 2018 Jan; 73(1):256-260. PubMed ID: 28859248
[TBL] [Abstract][Full Text] [Related]
37. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent.
Liu R; Hu S; Zhang Y; Che D; Cao J; Wang J; Zhao T; Jia Q; Wang N; Zhang T
Int Immunopharmacol; 2019 May; 70():417-427. PubMed ID: 30856392
[TBL] [Abstract][Full Text] [Related]
38. Importin beta plays an essential role in the regulation of the LysRS-Ap(4)A pathway in immunologically activated mast cells.
Carmi-Levy I; Motzik A; Ofir-Birin Y; Yagil Z; Yang CM; Kemeny DM; Han JM; Kim S; Kay G; Nechushtan H; Suzuki R; Rivera J; Razin E
Mol Cell Biol; 2011 May; 31(10):2111-21. PubMed ID: 21402779
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory function of Shikonin on MRGPRX2-mediated pseudo-allergic reactions induced by the secretagogue.
Wang J; Zhang Y; Li C; Ding Y; Hu S; An H
Phytomedicine; 2020 Mar; 68():153149. PubMed ID: 32032836
[TBL] [Abstract][Full Text] [Related]
40. MRGPRX2 mediates immediate-type pseudo-allergic reactions induced by iodine-containing iohexol.
Yuan F; Zhang C; Sun M; Wu D; Cheng L; Pan B; Li T; Che D
Biomed Pharmacother; 2021 May; 137():111323. PubMed ID: 33524790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
